181.
182.
Hacker gets seven years for breaching Rotterdam and Antwerp ports
(bleepingcomputer.com)
183.
Funding for Risky Biotechs Is Returning
(feeds.content.dowjones.io)
184.
Ozempic is changing the foods Americans buy
(news.ycombinator.com)
185.
Ozempic reduced grocery spending by an average of 5.3% in the US
(news.ycombinator.com)
186.
187.
188.
189.
Ozempic Quitters Pay a Heavy Price, Research Shows
(gizmodo.com)
190.
Revolution Medicines Draws Takeover Interest
(feeds.content.dowjones.io)
191.
AbbVie Near Deal for Revolution Medicines
(feeds.content.dowjones.io)
192.
Something Grim Is Happening to People Who Go Off GLP-1s
(futurism.com)
193.
Tips from pharmacists to lower your out-of-pocket drug costs
(feeds.feedburner.com)
194.
Drugmakers raise US prices on 350 medicines despite pressure
(news.ycombinator.com)
195.
People Jabbing Themselves With Black Market “GLP-3” Drugs
(futurism.com)
196.
197.
Wegovy is coming in pill form. Here’s when, how much, and how well it works
(feeds.feedburner.com)
198.
Forget job hunting. Gen Z is ‘growth hunting’
(feeds.feedburner.com)
199.
Lawsuits Allege Ozempic Is Causing Blindness
(futurism.com)
200.
ProPublica’s New Tool Provides Drug Info the FDA Won’t
(gizmodo.com)
201.
Heart and Kidney Diseases and Type 2 Diabetes May Be One Ailment
(news.ycombinator.com)
202.
203.
204.
Trials avoid high risk patients and underestimate drug harms
(news.ycombinator.com)
205.
A $20 drug in Europe requires a prescription and $800 in the U.S.
(news.ycombinator.com)
206.
Scientists Testing GLP-1s for Overweight Dogs and Cats
(futurism.com)
207.
A fentanyl vaccine is about to get its first major test
(arstechnica.com)
208.
209.
210.
More FDA drama: Top drug regulator calls it quits after 3 weeks
(arstechnica.com)